Status:
COMPLETED
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco Dependence
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
In this study, smokers will be randomly assigned to one of three conditions for six weeks: 1) nicotine-free cigarettes (0.05mg); 2) extra low nicotine cigarettes (0.3 mg); or 3) medicinal 4 mg nicotin...
Detailed Description
Smokers (N=150) will be enrolled in the study and will smoke ad libitum for a period of two weeks during which time they will be assessed for baseline measurements. Subjects will then be randomly assi...
Eligibility Criteria
Inclusion
- smoking between 10-40 cigarettes daily for the past year;
- in good physical health (no unstable medical condition;
- no contraindications for medicinal nicotine;
- stable, good mental health
Exclusion
- unwilling to use study products for 6 weeks;
- unstable medical or psychiatric condition.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00777569
Start Date
March 1 2005
End Date
November 1 2006
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univerisity of Minnesota
Minneapolis, Minnesota, United States, 55414